The Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) has come to its end on 31 January 2019. HA-REACT had 22 partners, representing 18 EU Member States, with additional expertise provided by 14 collaborating partners, including the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) who, through their work, have shown how funding and national policies affect harm reduction programmes.
HA-REACT was co-funded by the EU Health Programme.
The European-wide project had the ambitious objectives of ending new HIV cases and reducing HCV and tuberculosis (TB) transmission among people who inject drugs (PWID) in the EU by 2020 and focused on three EU countries (Hungary, Latvia and Lithuania) specifically. Through a range of activities ranging from HIV and HCV rapid testing trainings, to a condom vending machine pilot project in a Czech prison, and a mobile unit offering harm reduction services for people who inject drugs in Riga, HA-REACT demonstrated the European Commission’s commitment to harm reduction, and the many challenges associated with such services.